Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.

[1]  Y. Goltsev,et al.  CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.

[2]  S. Srinivasula,et al.  FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[3]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[4]  G. Kroemer,et al.  The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis , 1997, The Journal of experimental medicine.

[5]  B Johansson,et al.  Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. , 1997, Cancer research.

[6]  D. Goeddel,et al.  Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.

[7]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[8]  G. Nolan,et al.  The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. , 1997, Immunity.

[9]  R. Kofler,et al.  Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl‐2, but not by CrmA , 1997, FEBS letters.

[10]  S. Srinivasula,et al.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Anel,et al.  CPP32 inhibition prevents Fas‐induced ceramide generation and apoptosis in human cells , 1996, FEBS letters.

[12]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[13]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[14]  M. Raff,et al.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death , 1996, The Journal of cell biology.

[15]  C. Borner,et al.  Bcl-2 interrupts the ceramide-mediated pathway of cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[17]  P. Bray-Ward,et al.  Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. , 1996, Genomics.

[18]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[19]  J. A. Hobbs,et al.  Fas involvement in cytotoxicity mediated by human NK cells. , 1995, Cellular immunology.

[20]  G. Nolan,et al.  Efficient screening of retroviral cDNA expression libraries. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Oyaizu,et al.  Requirement of p56lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. , 1995, Biochemical and biophysical research communications.

[22]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[23]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[24]  G Berke,et al.  The CTL's kiss of death , 1995, Cell.

[25]  T. Saito,et al.  Fas-mediated cytotoxicity by freshly isolated natural killer cells , 1995, The Journal of experimental medicine.

[26]  M. Tewari,et al.  Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.

[27]  John Calvin Reed,et al.  Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity , 1995, Cell.

[28]  N. Lalwani,et al.  Fas ligation triggers apoptosis in macrophages but not endothelial cells , 1994, European journal of immunology.

[29]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.

[30]  B. Barres,et al.  Programmed cell death and the control of cell survival. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[31]  J. Weissenbach,et al.  A method for constructing radiation hybrid maps of whole genomes , 1994, Nature Genetics.

[32]  B. Barres,et al.  Programmed cell death and the control of cell survival: lessons from the nervous system. , 1993, Science.

[33]  P. Krammer,et al.  Activation interferes with the APO-1 pathway in mature human T cells. , 1993, International immunology.

[34]  S. Nagata,et al.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.

[35]  K. Hofmann,et al.  PROFILEGRAPH: an interactive graphical tool for protein sequence analysis , 1992, Comput. Appl. Biosci..

[36]  J. Wagner,et al.  Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia. , 1992, Cancer genetics and cytogenetics.

[37]  L. Owen-Schaub,et al.  DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. , 1992, Cellular immunology.

[38]  D. Cox.  Radiation hybrid mapping. , 1991, Cytogenetics and cell genetics.

[39]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[40]  P. Sharma,et al.  Acute myelomonocytic leukemia with bone marrow eosinophilia and inv(16)(p13q22),t(1;16)(q32;q22). , 1991, Cancer genetics and cytogenetics.

[41]  R. Myers,et al.  Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. , 1990, Science.

[42]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[43]  I. Jinnai,et al.  Transformation of bilineal hybrid acute leukemia to acute lymphoid leukemia: A case report with serial analyses of cytogenetics and gene rearrangement , 1990, American journal of hematology.

[44]  S. Lee,et al.  Role of 1q trisomy in tumorigenicity, growth, and metastasis of human leukemic B-cell clones in nude mice. , 1990, Cancer research.

[45]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[46]  J. Rowley,et al.  A cytogenetic study of children in India with acute lymphocytic leukemia: correlation with clinical data. , 1986, Cancer genetics and cytogenetics.

[47]  G. Nolan,et al.  Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Clot,et al.  In Vitro studies on human B and T cell purified populations. Stimulation by mitogens and allogeneic cells, and quantitative binding of phytomitogens. , 1975, Immunology.

[49]  D. Green,et al.  The end of the (cell) line: methods for the study of apoptosis in vitro. , 1995, Methods in cell biology.

[50]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[51]  U. Francke,et al.  Chromosomal mapping of genes involved in growth control. , 1986, Cold Spring Harbor symposia on quantitative biology.

[52]  J. Köhler,et al.  Involvement of chromosomes #1 and #11 in three cases with myeloproliferative diseases. , 1984, Cancer genetics and cytogenetics.